TLX News

TLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Telix Pharmaceuticals Limited to Contact the Firm Today!

TLX IMPORTANT DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action First Filed by the Firm - TLX

Investors Urged to Contact Levi & Korsinsky for Information Before January 9, 2026 - Telix Pharmaceuticals Ltd. (TLX)

Class Action Alert: Levi & Korsinsky Reminds Telix Pharmaceuticals Ltd. (TLX) Investors of January 9, 2026 Deadline

Bronstein, Gewirtz & Grossman LLC Urges Telix Pharmaceuticals Limited Investors to Act: Class Action Filed Alleging Investor Harm

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm

21% TLX PLUNGE: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

TLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Telix Pharmaceuticals Limited to Contact the Firm Today!

Pomerantz LLP Shares Class Action Details With Investors in Telix Pharmaceuticals Limited – TLX

January 9, 2026 Deadline: Join Class Action Lawsuit Against Telix Pharmaceuticals Ltd. (TLX) - Contact Levi & Korsinsky